Key result
The PROGRESS-CTO perforation score demonstrated acceptable performance for predicting clinical coronary perforation during CTO PCI (AUC 0.741; 95% CI 0.712-0.773).
Why the study?
Coronary artery perforation is a feared complication of chronic total occlusion PCI that often leads to serious adverse clinical events, motivating a risk score to predict it.
Can the PROGRESS-CTO perforation score predict clinical coronary artery perforation in patients undergoing CTO PCI?
Observational (n=9,618)
Yes
Can the PROGRESS-CTO perforation score predict clinical coronary artery perforation in patients undergoing CTO PCI?
Effect estimate: AUC 0.741 (95% CI 0.712-0.773)
The PROGRESS-CTO perforation score is a validated tool that can help predict the risk of clinical coronary perforation during CTO PCI based on five clinical and angiographic factors.
May inform perforation risk stratification in CTO PCI; leaves open prospective validation and outcome impact before routine use.
BACKGROUND: Coronary artery perforation is a feared complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and often leads to serious adverse clinical events. AIMS: We sought to develop a risk score to predict clinical coronary artery perforation in patients undergoing CTO PCI. METHODS: We analysed clinical and angiographic parameters from 9,618 CTO PCIs in the Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO). Logistic regression prediction modelling was used to identify variables independently associated with clinical perforation, and the model was internally validated with bootstrapping. Clinical coronary artery perforation was defined as any perforation requiring treatment. RESULTS: The incidence of clinical coronary perforation was 3.8% (n=367). Five factors were independently associated with perforation and were included in the score: patient age ≥65 years +1 point (odds ratio [OR] 1.79, 95% confidence interval [CI]: 1.37-2.33), moderate/severe calcification +1 point (OR 1.85, 95% CI: 1.41-2.42), blunt/no stump +1 point (OR 1.45, 95% CI: 1.10-1.92), use of antegrade dissection and re-entry +1 point (OR 2.43, 95% CI: 1.61-3.69), and use of the retrograde approach +2 points (OR 4.02, 95% CI: 2.95-5.46). The resulting score showed acceptable performance on receiver operating characteristic (ROC) curve (area under the curve [AUC]: 0.741, 95% CI: 0.712-0.773). The Hosmer-Lemeshow test indicated a good fit (p=0.991), and internal validation with bootstrapping demonstrated good agreement with the model with observed AUC: 0.736 (95% bias-corrected CI: 0.706-0.767). CONCLUSIONS: The PROGRESS-CTO perforation score may be a useful tool for predicting clinical coronary perforation during CTO PCI.
No takes yet. Share an insight, caveat, or question.
Simsek et al. (2023) conducted an observational in Chronic total occlusion (CTO) (n=9,618). PROGRESS-CTO perforation score was evaluated on Clinical coronary artery perforation (any perforation requiring treatment) (AUC 0.741, 95% CI 0.712-0.773). The PROGRESS-CTO perforation score demonstrated acceptable performance for predicting clinical coronary perforation during CTO PCI (AUC 0.741; 95% CI 0.712-0.773).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: